Background: Kaposi’s sarcoma (KS) is an angioproliferative malignancy caused by infection with human herpes virus -8 (HHV-8). The tumour has four subtypes including Classic KS, African- endemic, Iatrogenic and Acquired immunodeficiency syndrome (AIDS)-related KS. AIDS- related KS is the most common malignancy in patients with human immunodeficiency virus (HIV) infection and has variable clinical presentation with diverse distribution of lesions. Objective: To assess the pattern of distribution of KS lesions in patients with AIDS-related KS at Kenyatta National Hospital. Methods: We carried out a descriptive study on patients with HIV infection with histological diagnosis of KS. The study commenced upon approval by KNH-University of Nairobi...
Paper presented at the 5th Strathmore International Mathematics Conference (SIMC 2019), 12 - 16 Augu...
Kaposi’s sarcoma (KS) has become a common AIDS-defining cancer in sub-Saharan Africa. Kaposi’s sarco...
HIV-associated Kaposi's sarcoma (KS) is a public health challenge in sub-Saharan Africa since both t...
Background: Kaposi's sarcoma (KS) is associated epidemiologically with HIV infection and a number of...
Kaposi Sarcoma consists of several types differing in clinical and epidemiological patterns. In Sub-...
Background: Sub-Sahara Africa hosts up to 71 % of all HIV infected people in the world. With this hi...
Background. The incidence of Kaposi’s sarcoma (KS) has increased dramatically since the onset of the...
Kaposi’s sarcoma (KS) is a common vascular tumor arising in human immunodefi ciency virus (HIV) infe...
Background. HIV/AIDS-related Kaposi’s sarcoma (HIV-KS) is a public health problem in South Africa (S...
# Background Kaposi’s sarcoma became prevalent with the appearance of human immune deficiency virus...
Objectives: Kaposi sarcoma (KS) shows greater geographic variation in incidence than almost any othe...
Background/objective: Kaposi sarcoma (KS) is now the most frequently reported malignant skin tumour ...
ABSTRACTKaposi’s sarcoma (KS), caused by KS-associated herpesvirus (KSHV), is the most common cancer...
Kaposi sarcoma defined as a multifocal lesion in mucocutaneous sites which has low-grade malignant p...
Abstract: Background: Kaposi’s sarcoma (KS) is a rare neoplasm with indolent progression. Since 198...
Paper presented at the 5th Strathmore International Mathematics Conference (SIMC 2019), 12 - 16 Augu...
Kaposi’s sarcoma (KS) has become a common AIDS-defining cancer in sub-Saharan Africa. Kaposi’s sarco...
HIV-associated Kaposi's sarcoma (KS) is a public health challenge in sub-Saharan Africa since both t...
Background: Kaposi's sarcoma (KS) is associated epidemiologically with HIV infection and a number of...
Kaposi Sarcoma consists of several types differing in clinical and epidemiological patterns. In Sub-...
Background: Sub-Sahara Africa hosts up to 71 % of all HIV infected people in the world. With this hi...
Background. The incidence of Kaposi’s sarcoma (KS) has increased dramatically since the onset of the...
Kaposi’s sarcoma (KS) is a common vascular tumor arising in human immunodefi ciency virus (HIV) infe...
Background. HIV/AIDS-related Kaposi’s sarcoma (HIV-KS) is a public health problem in South Africa (S...
# Background Kaposi’s sarcoma became prevalent with the appearance of human immune deficiency virus...
Objectives: Kaposi sarcoma (KS) shows greater geographic variation in incidence than almost any othe...
Background/objective: Kaposi sarcoma (KS) is now the most frequently reported malignant skin tumour ...
ABSTRACTKaposi’s sarcoma (KS), caused by KS-associated herpesvirus (KSHV), is the most common cancer...
Kaposi sarcoma defined as a multifocal lesion in mucocutaneous sites which has low-grade malignant p...
Abstract: Background: Kaposi’s sarcoma (KS) is a rare neoplasm with indolent progression. Since 198...
Paper presented at the 5th Strathmore International Mathematics Conference (SIMC 2019), 12 - 16 Augu...
Kaposi’s sarcoma (KS) has become a common AIDS-defining cancer in sub-Saharan Africa. Kaposi’s sarco...
HIV-associated Kaposi's sarcoma (KS) is a public health challenge in sub-Saharan Africa since both t...